NCT01393743View on ClinicalTrials.gov

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2015

Conditions
Seizure Disorder Generalized Tonic Clonic
Interventions
DRUG

Perampanel

DRUG

Placebo comparator

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT01393743 - A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures | Biotech Hunter | Biotech Hunter